Fda approval apidra insulin glulisine 2004?

Yes. The FDA granted approval for Apidra® (insulin glulisine) in 2004. The drug was approved on February 19, 2004 as the first rapid‑acting insulin analog for mealtime use in people with type 1 and type 2 diabetes. It’s now available under the brand name Apidra® (Eli Lilly) and can be used as part of a basal–bolus insulin regimen.